Discover the power of real-time signals plus AI
Every contract, funding round, exec hire, and M&A move on Amyris — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
Amyris Awarded Agreement from BioMaP-Consortium for $12.3 million to Develop Critical Medicines
Contract Type
agreement
Description
Amyris has been awarded an agreement through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C) for $12.3 million from the Administration for Strategic Preparedness and Response's (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC) to advance innovative pharmaceutical manufacturing in the United States. Amyris aims to develop up to three small molecule drugs over the next two years to address the FDA drug shortage list.
Related People
Sign in to view contact details